Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cell and Tissue Banking is Scopus-indexed (Q2, CiteScore 4.7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer Netherlands.
Checked against the index lists dated .
ISSN 1389-9333Verify ISSN ↗1573-6814Verify ISSN ↗
Publisher: Springer Netherlands
Cost to publish: About US$3,990 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Transplantation | 19 / 55 | 66th | Q2 |
| Biomedical Engineering | 164 / 342 | 52nd | Q2 |
| Biomaterials | 80 / 146 | 45th | Q3 |
| Cell Biology | 185 / 289 | 35th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2000–present, best quartile Q2, CiteScore 4.7.
Cell and Tissue Banking is Q2 in Transplantation (rank 19 of 55), Q2 in Biomedical Engineering (rank 164 of 342) and Q3 in Biomaterials (rank 80 of 146), by CiteScore 2025. It is ranked in 4 subject areas in all.
Cell and Tissue Banking is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.7, which places it in quartile Q2 at the 66th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.554, quartile Q2, with an H-index of 58.
The publisher lists an article processing charge of about US$3,990 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cell and Tissue Banking is published by Springer Netherlands. Its print ISSN is 1389-9333 and its online ISSN is 1573-6814.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Cell and Tissue Banking has an h-index of 63 and a 2-year mean of 1.95 citations per paper (OpenAlex). Its Scopus CiteScore is 4.7, quartile Q2. On 2-year citations it ranks #12 of 53 Scopus journals in Transplantation.
Cell and Tissue Banking published 51 papers in 2025; its busiest recent year was 2021 with 96. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2024–2026), authors are most often from Iran (14.1%), China (9.6%) and Brazil (9.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 5 retracted papers are recorded (3.2 per 1,000 papers). The Problematic Paper Screener flags 2 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.